Study guide
18.3 Medication Routes: Enteral, Parenteral, Inhaled & Topical Administration
COPR Primary Care Paramedic PCP
Track your progress as you read
Finished sections get a check mark.
1 Introduction: The COPR PCP Exam & How to Use This Guide
0.1 About the COPR PCP Entry-to-Practice Examination 0.2 The 2024 CPCF Blueprint: Competence Areas, Weights & Question Targets 0.3 Eligibility, Attempts, Accommodations & a 12-Week Study Plan
2 Chapter 1: Professionalism, Ethics & Legal Framework
1.1 Ethical Practice, Professionalism & Values in Canadian Paramedicine 1.2 Professional Accountability, Candour & Duty to Report 1.3 Regulatory Framework, Scope of Practice & Informed Consent
3 Chapter 2: Patient-Centred Communication & Clinical Documentation
2.1 Therapeutic Communication, Empathy & De-escalation 2.2 Patient-Centred Interviewing & Comprehensive History Gathering 2.3 Clinical Information Sharing, Consent & Incident Disclosure 2.4 Clinical Documentation, Electronic Health Records & Privacy 2.5 Shared Decision-Making, Health Literacy & Engaging Patients in Care Plans
4 Chapter 3: Interprofessional Collaboration & Continuum of Care
3.1 Care Team Roles, Task Delegation & Shared Decision-Making 3.2 Scene Collaboration, Interagency Conflict & Safety Culture 3.3 Safe Transfer of Care, Clinical Handover & Transition Plans
5 Chapter 4: Evidence-Informed Practice & Continuing Competence
4.1 Clinical Mentorship, Role Modelling & Reflective Debriefing 4.2 Evidence-Informed Practice, Guideline Translation & Lifelong Learning 4.3 Continuing Competence, Personal Learning Plans & Adapting to a Changing Profession
6 Chapter 5: Professional Health, Safety & Operational Resilience
5.1 Paramedic Wellness, Occupational Stress Injuries & PTSI Recognition 5.2 Fitness for Duty, Ergonomics, Safe Lifting & Peer Support Systems 5.3 Monitoring Personal Health, Healthy Coping & Removing Yourself from Practice
7 Chapter 6: Health Advocacy, Equity & Culturally Safe Care
6.1 Social Determinants of Health, Cultural Safety & Anti-Oppressive Practice 6.2 Anti-Indigenous Racism, Truth and Reconciliation & Trauma-Informed Care 6.3 System-Level Advocacy, Social Accountability & Working Toward Reconciliation
8 Chapter 7: Situational Leadership & Scene Operations
7.1 Prehospital Scene Assessment, Initial Incident Command & Hazard Mitigation 7.2 Clinical Resource Coordination & Practice Improvement Systems
9 Chapter 8: Infection Prevention, Diagnostics & Scene Preparedness
8.1 Infection Prevention and Control: Routine Practices, PPE & Sharps Safety 8.2 Point-of-Care Risk Assessment & Mass Casualty/CBRNE Principles 8.3 Paramedic Scope along the Continuum & Diagnostic Laboratory Correlation 8.4 Point-of-Care Risk Assessment, Situational Awareness & Securing Additional Resources
10 Chapter 9: Patient Assessment, Physical Examination & Vital Signs
9.1 Primary Survey, Rapid Trauma/Medical Exam & Threat Identification 9.2 Secondary Assessment, History Integration (SAMPLE/OPQRST) & Lifespan Adaptation 9.3 Vital Signs Interpretation, Glasgow Coma Scale & Clinical Reassessment
11 Chapter 10: Diagnostic Monitoring: ECG & Capnography
10.1 Prehospital Pulse Oximetry, Glucometry & Urinalysis 10.2 Prehospital Electrocardiography: 3-Lead Monitoring & 12-Lead Acquisition 10.3 Continuous Waveform Capnography (EtCO2) & Ventilation Dynamics
12 Chapter 11: Airway Management & Ventilation Therapeutics
11.1 Basic Airway Maneuvers, Positioning, OPA/NPA & Suctioning Techniques 11.2 Supraglottic Airway (SGA) Devices & Tracheostomy Management 11.3 Oxygen Delivery Modalities, Regulators & Safety 11.4 Positive Pressure Ventilation, BVM Mechanics, PEEP & CPAP 11.5 Foreign Body Airway Obstruction: Recognition & Relief Across the Lifespan 11.6 Beyond CPAP: BiPAP, High-Flow Nasal Cannula Therapy & Choosing a Ventilation Strategy
13 Chapter 12: Cardiovascular Emergencies & Resuscitative Care
12.1 High-Performance Cardiopulmonary Resuscitation (CPR) & Automated/Manual Defibrillation 12.2 Acute Coronary Syndromes (ACS), STEMI Recognition & Pathophysiology 12.3 Heart Failure, Cardiogenic Shock & Left Ventricular Assist Devices (LVAD) 12.4 Cardiovascular Pharmacotherapy: Nitroglycerin, ASA & Epinephrine
14 Chapter 13: Trauma Emergencies, Hemorrhage Control & SMR
13.1 External Hemorrhage Control: Tourniquets, Wound Packing & Pelvic Binders 13.2 Spinal Motion Restriction (SMR) & Canadian C-Spine Rule Application 13.3 Thoracic & Abdominal Trauma Management 13.4 Musculoskeletal Trauma, Fractures, Splinting & Dislocation Reduction 13.5 Head Injury & Traumatic Brain Injury: Preventing Secondary Brain Injury 13.6 Burns and Soft-Tissue Injury: Thermal, Chemical, Electrical & Inhalation
15 Chapter 14: Medical, Endocrine, Toxicological & Environmental Emergencies
14.1 Acute Respiratory Distress: Asthma, COPD, Pulmonary Edema & Anaphylaxis 14.2 Neurological Emergencies: Stroke Syndromes, TIA, Seizures & Status Epilepticus 14.3 Endocrine Emergencies: Hypoglycemia, DKA/HHS & Glucagon/Dextrose Administration 14.4 Toxicological Emergencies, Opioid Toxicity, Naloxone & Environmental Exposure 14.5 Abdominal, Gastrointestinal & Hepatobiliary Emergencies 14.6 Genitourinary, Renal & Dialysis Emergencies 14.7 Haematologic, Immunologic, EENT & Dental Emergencies
16 Chapter 15: Special Populations: Obstetrics & Neonatal Resuscitation
15.1 Antepartum Emergencies, Preeclampsia & Normal Spontaneous Childbirth 15.2 Complicated Deliveries: Breech, Prolapsed Cord, Nuchal Cord & Postpartum Hemorrhage 15.3 Neonatal Resuscitation Program (NRP) in the Prehospital Setting
17 Chapter 16: Special Populations: Pediatrics, Geriatrics, Palliative & Vulnerable Patients
16.1 Pediatric Assessment Triangle (PAT), Common Emergencies & Pediatric Dosing 16.2 Geriatric Syndromes, Polypharmacy, Elder Vulnerability & Falls 16.3 Palliative Emergencies, Medical Assistance in Dying (MAID) & Community Paramedicine 16.4 Bariatric Patients, Limited Mobility & Patients With Different Abilities
18 Chapter 17: Clinical Foundations — Terminology, Anatomy, Physiology & Pathophysiology
17.1 Medical & Paramedic Terminology, Abbreviations and Anatomical Reference 17.2 Applied Anatomy & Physiology Across Body Systems and the Lifespan 17.3 Core Pathophysiology: Cellular Injury, Hypoperfusion & the Shock States
19 Chapter 18: Pharmacology & Safe Medication Administration
18.1 Pharmacology Foundations: Classification, Pharmacokinetics & Pharmacodynamics 18.2 Safe Medication Administration: The Rights, Dose Calculation & Error Management 18.3 Medication Routes: Enteral, Parenteral, Inhaled & Topical Administration
20 Chapter 19: Vascular Access, Fluid Therapy, Routine Care & Patient Movement
19.1 Peripheral IV Cannulation, Venipuncture, Saline Locks & Maintaining Infusions 19.2 Intraosseous Access, Crystalloid Fluid Therapy, Pressure Infusers & Blood Products 19.3 Routine Care: Urinary Catheters, Ostomy & Drainage Systems, Chest Tubes & Wound Care 19.4 Patient Handling, Movement, Positioning & Transfer to a Higher Level of Care
21 Chapter 20: Mental Health, Behavioural Emergencies & Substance Use
20.1 Mental Status Assessment, Cognition & Capacity to Consent 20.2 Behavioural Emergencies, Severe Agitation & Safe Restraint 20.3 Substance Use, Addictions, Withdrawal & Harm Reduction
18.3 Medication Routes: Enteral, Parenteral, Inhaled & Topical Administration
Key Takeaways Explain This Topic AI
CPCF skill #32 names eleven routes: buccal, endotracheal, inhalation, intramuscular, intranasal, intraosseous, intravenous, oral, subcutaneous, sublingual, and topical.
Sublingual, buccal, inhaled, topical, and all parenteral routes bypass first-pass hepatic metabolism; the oral route does not.
The vastus lateralis is the preferred intramuscular site for epinephrine in anaphylaxis at every age, and the dorsogluteal site should be avoided entirely.
Intranasal doses are split between both nostrils because each absorbs only about 0.5 to 1 mL, and effectiveness falls with epistaxis, mucus, or prior vasoconstrictor use.
Intramuscular and subcutaneous absorption depends on perfusion and fails in shock, and nothing is placed in the mouth of a patient who cannot protect their airway.
Last updated: September 2026
18.3 Medication Routes: Enteral, Parenteral, Inhaled & Topical Administration
CPCF Appendix A minimum entry-to-practice skill #32 names eleven routes the Primary Care Paramedic must be able to use: buccal, endotracheal, inhalation (not including oxygen), intramuscular, intranasal, intraosseous, intravenous, oral, subcutaneous, sublingual, and topical. Foundational knowledge #5 adds the characteristics of injection sites and the preparation of patient and supplies. Which routes a given PCP may actually use depends on the provincial regulator and the medical directive — but all eleven are examinable content.
Choosing a Route
The choice is driven by three questions: how fast is the effect needed , is the drug formulated for that route , and can this patient use it safely .
- Route Typical onset Bypasses first pass? Key limitation
- Intravenous Seconds Yes Requires access; irreversible once given
Intraosseous Seconds (equivalent to IV) Yes Painful in conscious patients; requires specific contraindication check
- Endotracheal 1–2 min, erratic Yes Unreliable absorption; a last resort only
- Inhalation 1–5 min Yes Requires adequate tidal volume and cooperation
- Sublingual / buccal 1–5 min Yes Requires a moist mucosa and a cooperative patient
- Intranasal 3–5 min Yes Limited volume per nostril; reduced by epistaxis or vasoconstrictors
- Intramuscular 10–20 min Yes Unreliable in shock; absorption depends on perfusion
- Subcutaneous 15–30 min Yes Slowest parenteral route; very unreliable in shock
- Topical / transdermal Minutes to hours Yes Absorption varies with skin condition and perfusion
- Oral 30–90 min No Useless if the patient cannot swallow or is vomiting
- Enteral Routes
- Oral (PO)
Simplest and safest when appropriate, but subject to first-pass metabolism and requiring an intact swallow and protective airway reflexes.
Contraindicated in decreased level of consciousness, absent gag, active vomiting, suspected bowel obstruction, and in any patient likely to need urgent surgery or anaesthesia.
Oral glucose gel is a common PCP medication and requires an alert, cooperative patient able to swallow. Never place gel in the mouth of a patient who cannot protect their airway.
Chewable ASA is chewed rather than swallowed to accelerate absorption across the buccal and upper gastrointestinal mucosa.
Sublingual (SL) and Buccal
Placed under the tongue (sublingual) or between the cheek and gum (buccal). Both mucosae are thin, highly vascular, and drain into veins returning directly to the systemic circulation, bypassing first-pass hepatic metabolism — the reason sublingual nitroglycerin works when swallowed nitroglycerin does not.
Requires a moist mucosa: a dry mouth substantially slows absorption. Moisten with a little water if needed.
The patient must not swallow the tablet or spray, and must not eat or drink until it has dissolved.
Do not use in an unconscious patient or one who cannot follow the instruction.
Sublingual nitroglycerin (spray or tablet) and buccal or sublingual glucose preparations are the common prehospital examples.
- Parenteral Routes
- Intramuscular (IM)
Deposits drug into well-perfused skeletal muscle for absorption via the capillary bed. Onset is 10 to 20 minutes and absorption depends entirely on perfusion , so it is unreliable in shock.
Site Landmarks Volume Notes
Vastus lateralis (anterolateral thigh) Middle third of the thigh, lateral aspect Up to ~5 mL adult; ~1–2 mL infant Preferred for epinephrine in anaphylaxis at every age; large, vascular, no major nerves or vessels; the only recommended site in infants
Deltoid 2–3 finger-widths below the acromion Up to ~2 mL Convenient but small; risk to the axillary and radial nerves if placed too low
Ventrogluteal Palm on greater trochanter, index to anterior superior iliac spine, injection in the V Up to ~5 mL Safest gluteal site; avoids the sciatic nerve
Dorsogluteal Upper outer quadrant of the buttock — Avoid — sciatic nerve injury risk and slow, unreliable absorption through overlying fat
Technique: 21–25 gauge needle, 90-degree angle, length chosen so the drug reaches muscle and not subcutaneous fat, skin cleaned and allowed to dry, and the site documented.
Subcutaneous (SC)
Into the loose connective tissue beneath the dermis — outer upper arm, anterior thigh, or abdomen. Small volumes only (generally up to about 1 mL), 25–27 gauge needle, 45- to 90-degree angle depending on tissue depth. Onset 15 to 30 minutes and highly unreliable in shock . Rotate sites in patients who inject regularly, as lipohypertrophy impairs absorption.
Intravenous (IV)
The fastest and most reliable route, with 100% bioavailability and no absorption phase. Cannulation technique, site selection, and maintenance are covered in Section 19.1.
Once given, it cannot be retrieved — which is why the rights and the independent double check matter most here.
Give at the rate the drug requires; rapid push of some drugs causes hypotension or dysrhythmia.
Flush after each drug , particularly in cardiac arrest, where a 20 mL flush with limb elevation moves the drug from a peripheral vein into the central circulation.
Check patency and watch the site: extravasation of an irritant such as D50W causes tissue necrosis.
Intraosseous (IO)
Into the medullary cavity, a non-collapsible venous plexus that drains directly into the central circulation. Onset and dosing are equivalent to intravenous . Covered in Section 19.2.
Intranasal (IN)
Delivered as a fine mist through a mucosal atomization device onto the highly vascular nasal mucosa, from which some drug also reaches the central nervous system directly along the olfactory route.
No needle , so it is fast to deploy, safe in an agitated or seizing patient, and eliminates sharps risk — the principal reason naloxone and midazolam are commonly given this way.
Split the dose between both nostrils — each nostril absorbs a limited volume, generally about 0.5 to 1 mL, and exceeding it means the excess is swallowed and wasted.
Use a concentrated formulation so the volume stays small.
Reduced effectiveness with epistaxis, copious mucus, nasal trauma, prior use of a vasoconstrictor spray, or septal disease.
Endotracheal (ET)
Instillation of certain drugs down an endotracheal tube for absorption across the alveolar membrane. Absorption is erratic and unreliable , higher doses are required, and it is a last resort used only when no intravenous or intraosseous access can be obtained and only for the limited set of drugs that tolerate it. It is listed in skill #32 as knowledge, not as a preferred technique.
Inhalation
Delivery of an aerosolized or nebulized drug to the respiratory mucosa and alveoli for rapid local and systemic effect. Note that skill #32 specifies inhalation not including oxygen — oxygen administration is covered separately under skills #22 and #23.
Nebulizer: drug is driven by gas flow, typically 6 to 8 L/min, into a mist. Requires only tidal breathing, so it works in a distressed patient. Common prehospital use: salbutamol , with or without ipratropium.
Metered-dose inhaler with a spacer: as effective as a nebulizer for most patients when technique is correct, faster to deploy, and does not aerosolize as much. Requires coordination or a spacer with a mask.
Effectiveness depends on tidal volume and flow. A patient too exhausted to generate flow will not receive the drug; that patient needs assisted ventilation, through which the nebulized drug can often be delivered in line.
Aerosol-generating — a point-of-care risk assessment governs the protective equipment used (Section 8.4).
Topical and Transdermal
Applied to skin or mucous membrane for local effect or, with transdermal formulations, for systemic absorption through the skin.
Wear gloves. Self-administration by absorption through the paramedic's own skin is a real and documented hazard with nitroglycerin paste and fentanyl patches.
Absorption rises with heat, broken skin, and increased perfusion — a patient with a fentanyl patch who becomes febrile or is actively warmed can absorb substantially more drug.
Remove existing patches when they may be contributing to toxicity, document removal, and account for the patch — and check for a patch in any unexplained decreased level of consciousness, including on the back, under breast tissue, and between skin folds.
Do not place defibrillation pads over a medication patch. Remove the patch, wipe the area, and then apply the pad; the metallic backing on some patches can arc and cause burns.
Tip
Three route errors recur on examinations. First, 1:1,000 epinephrine is never given intravenously as a bolus in anaphylaxis — it is intramuscular into the anterolateral thigh. Second, nothing goes in the mouth — not glucose gel, not a sublingual tablet — for a patient who cannot protect their airway. Third, intramuscular and subcutaneous absorption fails in shock , so a patient who is poorly perfused needs an intravenous or intraosseous route for any time-critical drug.